文献速递关节外科

多数初次全髋与全膝关节置换术后无需常规检测全血细胞计数

Routine Postoperative Complete Blood Counts Are Not Necessary After Most Primary Total Hip and Knee Arthroplasties.
PubMed 文献 · J Arthroplasty · 2020-10-29

该单中心回顾性研究纳入1060例初次全膝或全髋关节置换患者,总体输血率为0.66%(7/1060),术前血红蛋白大于12 g/dL者中仅1例输血(1/976;0.1%),无因急性失血性贫血导致的90天再入院。作者认为,在氨甲环酸给药且术前血红蛋白≥12 g/dL的绝大多数患者中,术后常规全血细胞计数并非绝对必要且不提供额外价值。

要点

  • 总体输血率为0.66%(7/1060),术前Hb>12 g/dL者中仅1例输血(1/976;0.1%)。
  • 阿司匹林组与直接口服抗凝药组术前至术后第1天Hb变化无差异(P = .73)。
  • 无因急性失血性贫血导致的90天再入院。

核心结论

  • 作者认为,在氨甲环酸给药且术前血红蛋白等于或大于12 g/dL的绝大多数患者中,术后常规全血细胞计数检测并非绝对必要,且不提供额外价值。
  • 作者认为这可以减少患者不必要的检测并增加医疗系统节省。

研究设计与样本

  • 单中心回顾性队列研究,纳入1060例接受全膝关节或全髋关节置换的患者。
  • 收集的数据包括患者人口学特征、术前与术后实验室结果、氨甲环酸使用、术前与术后静脉血栓栓塞预防及抗凝药物,以及90天贫血相关再入院。
  • 证据等级为Level 3,回顾性队列。

主要发现

  • 全部患者的输血率为0.66%(7/1060)。
  • 术前血红蛋白大于12 g/dL的患者中仅1例输血(1/976;0.1%)。
  • 阿司匹林组与直接口服抗凝药组术前至术后第1天血红蛋白水平变化无差异(P = .73)。
  • 无因急性失血性贫血导致的90天再入院。

关键数值与推荐

  • 术前血红蛋白大于12 g/dL且使用氨甲环酸的患者中,输血为1/976(0.1%)。
  • 全部患者输血率为0.66%(7/1060)。
  • 阿司匹林组与直接口服抗凝药组术前至术后第1天血红蛋白变化比较P = .73。

临床怎么用

  • 作者认为,在氨甲环酸给药且术前血红蛋白等于或大于12 g/dL的绝大多数患者中,术后常规全血细胞计数检测并非绝对必要且不提供额外价值。
  • 作者认为这可减少患者不必要的检测并增加医疗系统节省。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Routine postoperative complete blood count tests are commonplace after total joint arthroplasty. The goal of this study was to identify if these result in any clinically meaningful action and if it would be safe to forego this testing in a population without known risk factors for transfusion. METHODS: A retrospective review of 1060 patients undergoing a total knee or total hip arthroplasty at a single institution was performed. Data points including patient demographics, preoperative and postoperative laboratory results, tranexamic acid use, preoperative and postoperative medication for venous thromboembolism prophylaxis and anticoagulation, as well as 90-day readmission related to anemia were collected. RESULTS: The transfusion rate for all patients was 0.66% (7/1060) and there was only one transfusion for a patient with a preoperative hemoglobin (Hb) greater than 12 g/dL (1/976; 0.1%). There was no difference in the change from preoperative to postoperative day 1 Hb levels in patients treated with aspirin compared with those on direct oral anticoagulation (P = .73). There were no 90-day readmissions related to acute blood loss anemia. CONCLUSIONS: This study demonstrates that routine postoperative complete blood count testing is not absolutely necessary and does not provide additional value in the vast majority of patients with preoperative Hb levels equal to or greater than 12 g/dL when tranexamic acid is administered. This could avoid unnecessary testing in patients and increased savings to the health care system. LEVEL OF EVIDENCE: Level 3, retrospective cohort.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Gilde AK, Downes KL, Leverett S, et al. Routine Postoperative Complete Blood Counts Are Not Necessary After Most Primary Total Hip and Knee Arthroplasties. J Arthroplasty. 2020. PMID: 33246786. doi:10.1016/j.arth.2020.10.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。